The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Open accessAbstract
SUMMARY The NF‐&kgr;B pathway plays a crucial role in supporting tumor initiation, progression, and radioresistance of tumor cells. However, the role of the NF‐&kgr;B pathway in radiation‐induced anti‐tumor host immunity remains unclear. Here we demonstrated that inhibiting the canonical NF‐&kgr;B pathway dampened the therapeutic effect of ionizing radiation (IR), whereas non‐canonical NF‐&kgr;B deficiency promoted IR‐induced anti‐tumor immunity. Mechanistic studies revealed that non‐canonical NF‐&kgr;B signaling in dendritic cells (DCs) was activated by the STING sensor‐dependent DNA‐sensing pathway. By suppressing recruitment of the transcription factor RelA onto the Ifnb promoter, activation of the non‐canonical NF‐&kgr;B pathway resulted in decreased type I IFN expression. Administration of a specific inhibitor of the non‐canonical NF‐&kgr;B pathway enhanced the anti‐tumor effect of IR in murine models. These findings reveal the potentially interactive roles for canonical and non‐canonical NF‐&kgr;B pathways in IR‐induced STING‐IFN production and provide an alternative strategy to improve cancer radiotherapy. Graphical Abstract Figure. No caption available. HIGHLIGHTSCanonical NF‐&kgr;B pathway is required for radiation‐induced anti‐tumor immunityNon‐canonical NF‐&kgr;B deficiency promotes anti‐tumor immunity after radiotherapyNon‐canonical NF‐&kgr;B pathway inhibits radiation‐induced STING‐mediated type I IFNsInhibiting non‐canonical NF‐&kgr;B pathway potentiates the therapeutic effect of radiation &NA; It is known that the NF‐&kgr;B pathway plays a crucial role in supporting tumor initiation, progression, and the radioresistance of tumor cells. Hou et al. demonstrate that the deficiency of non‐canonical NF‐&kgr;B, but not canonical NF‐&kgr;B, promotes radiation‐induced anti‐tumor immunity by regulating the STING‐mediated type I IFN expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
Self-citationInterleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Self-citationInterferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
Corrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
Self-citationType I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum, R. R., Liang, H., Deng, L., & Fu, Y.-X. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,070
Self-citationLugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966
Dendritic Cells and Cancer Immunity
Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 907
Burnette, B. C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N. N., Weichselbaum, R. R., Fu, Y.-X., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 878
Self-citationThe diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Radiation-induced bystander signalling in cancer therapy
Prise, K. M., & O'Sullivan, J. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2603 · Cited by 810
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Nelson, J. D., Denisenko, O., & Bomsztyk, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.27 · Cited by 770
Abe, T., & Barber, G. N. (2014) · Journal of Virology · doi:10.1128/jvi.00037-14 · Cited by 767
The noncanonical NF‐κB pathway
Sun, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01088.x · Cited by 722
PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
Tang, H., Liang, Y., Anders, R. A., Taube, J. M., Qiu, X., Mulgaonkar, A., Liu, X., Harrington, S. M., Guo, J., Xin, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96061 · Cited by 524
Self-citationHost STING-dependent MDSC mobilization drives extrinsic radiation resistance
Liang, H., Deng, L., Hou, Y., Meng, X., Huang, X., Rao, E., Zheng, W., Mauceri, H., Mack, M., Xu, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01566-5 · Cited by 488
Self-citationRadiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Gupta, A., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita, H., Schwendener, R., Pruschy, M., Knuth, A., & van den Broek, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446
Ionizing radiation induces expression and binding activity of the nuclear factor kappa B.
Brach, M. A., Hass, R., Sherman, M. L., Gunji, H., Weichselbaum, R., & Kufe, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115354 · Cited by 408
Self-citationCaamaño, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventós-Suárez, C., Snapper, C. M., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.185 · Cited by 395
Takeshima, T., Chamoto, K., Wakita, D., Ohkuri, T., Togashi, Y., Shirato, H., Kitamura, H., & Nishimura, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2982 · Cited by 243
Nuclear factor-κB: a friend or a foe in cancer?
Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 228
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Wang, X., Belguise, K., Kersual, N., Kirsch, K. H., Mineva, N. D., Galtier, F., Chalbos, D., & Sonenshein, G. E. (2007) · Nature Cell Biology · doi:10.1038/ncb1559 · Cited by 209
Shih, V. F.-S., Davis-Turak, J., Macal, M., Huang, J. Q., Ponomarenko, J., Kearns, J. D., Yu, T., Fagerlund, R., Asagiri, M., Zuniga, E. I., et al. (2012) · Nature Immunology · doi:10.1038/ni.2446 · Cited by 177
NF-κB RelA Subunit Is Crucial for Early IFN-β Expression and Resistance to RNA Virus Replication
Wang, J., Basagoudanavar, S. H., Wang, X., Hopewell, E. L., Albrecht, R. A., García‐Sastre, A., Balachandran, S., & Beg, A. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000114 · Cited by 168
Liang, H., Deng, L., Chmura, S., Burnette, B., Liadis, N., Darga, T., Beckett, M. A., Lingen, M. W., Witt, M., Weichselbaum, R. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202612 · Cited by 165
Self-citationWang, W., Abbruzzese, J. L., Evans, D. B., & Chiao, P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202833 · Cited by 161
Targeting the NF-κB Pathway in Cancer Therapy
Erstad, D. J., & Cusack, J. C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.011 · Cited by 151
Jin, J., Hu, H., Li, H. S., Yu, J., Xiao, Y., Brittain, G. C., Zou, Q., Cheng, X., Mallette, F. A., Watowich, S. S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.006 · Cited by 143
The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
Jin, J., Xiao, Y., Chang, J.-H., Yu, J., Hu, H., Starr, R., Brittain, G. C., Chang, M., Cheng, X., & Sun, S.-C. (2012) · Nature Immunology · doi:10.1038/ni.2423 · Cited by 136
Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen, X., Shen, B., Xia, L., Khaletzkiy, A., Chu, D. T. W., Wong, J. Y. C., & Li, J. J. (2002) · PubMed · Cited by 102
Josson, S., Xu, Y., Fang, F., Dhar, S. K., Clair, D. K. S., & Clair, W. H. S. (2005) · Oncogene · doi:10.1038/sj.onc.1209186 · Cited by 97
Vallabhapurapu, S., Noothi, S. K., Pullum, D. A., Lawrie, C. H., Pallapati, R. R., Potluri, V., Kuntzen, C., Khan, S., Plas, D. R., Orlowski, R. Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms9428 · Cited by 69
Xu, Y., Fang, F., Clair, D. K. S., Sompol, P. M., Josson, S., & Clair, W. H. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0238 · Cited by 60
Mineva, N. D., Wang, X., Yang, S., Ying, H., Xiao, Z. J., Holick, M. F., & Sonenshein, G. E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21765 · Cited by 41
The Inhibitory Effect of IFN-γ on Protease HTRA1 Expression in Rheumatoid Arthritis
Hou, Y., Lin, H., Zhu, L., Liu, Z., Hu, F., Shi, J., Yang, T., Shi, X., Guo, H., Tan, X., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302700 · Cited by 36
Self-citation
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Dendritic cells in cancer immunology and immunotherapy
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,574
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
McLaughlin, M., Patin, E. C., Pedersen, M., Wilkins, A., Dillon, M. T., Melcher, A. A., & Harrington, K. J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0246-1 · Cited by 883
Metadata
- Authors
- Hou, Y., Liang, H., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M., Mauceri, H., Arina, A., Weichselbaum, R. R., & Fu, Y.-X.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 49
- Issue
- 3
- Pages
- 490-503.e4
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2889057287
- Cited by
- 265
- References
- 43
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.